Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cancer Discov. 2018 Feb 26;8(5):648–661. doi: 10.1158/2159-8290.CD-17-1452

Figure 4. Sensitivity of MEK1 mutants to allosteric MEK inhibitors is associated with their RAF dependency.

Figure 4

A–C, WT or mutant MEK1 tagged with V5 were expressed in NIH3T3 cells upon cultured in medium containing doxycycline (300 ng/ml) for 24 hrs. Cells were then treated for 1 hr with increasing concentrations of three different allosteric MEK1 inhibitors CH5126766 (A) or PD901 (B) or Trametinib (C). IC50 of p-ERK inhibition to all three drugs were calculated on the basis of densitometry analysis of western blot results.